X0202 4 2007-02-06 0000902622 ICAGEN INC ICGN 0001239241 EVNIN ANTHONY B C/O VENROCK ASSOCIATES 30 ROCKEFELLER PLAZA, ROOM 5508 NEW YORK NY 10112 1 0 0 0 Common Stock 2007-02-06 4 P 0 431957 1.38 A 1136812 I By Fund Common Stock 2007-02-06 4 P 0 621597 1.38 A 1587593 I By Fund Warrant (Right to Buy) 1.45 2007-02-06 4 P 0 151184 .125 A 2007-02-06 2012-02-06 Common Stock 151184 151184 I By Fund Warrant (Right to Buy) 1.45 2007-02-06 4 P 0 217558 .125 A 2007-02-06 2012-02-06 Common Stock 217558 217558 I By Fund The common stock and warrants reported herein were purchased in a private placement that closed on February 6, 2007. The purchase price for each share is $1.38, which was the closing bid price of the Issuer's common stock as reported on the Nasdaq Global Market on January 25, 2007. For each one share purchased by a purchaser in the private placement, such purchaser received a warrant to purchase 0.35 shares of the Issuer's common stock at a price of $1.45 per share. The purchase price for each warrant is $0.125 per each underlying share of common stock. Securities held of record by Venrock Associates, a limited partnership of which Anthony B. Evnin is a General Partner. Mr. Evnin disclaims beneficial ownership of these securities except to the extent of his pro-rata interest. Securities held of record by Venrock Associates II, L.P., a limited partnership of which Anthony B. Evnin is a General Partner. Mr. Evnin disclaims beneficial ownership of these securities except to the extent of his pro-rata interest. The warrants are immediately exercisable and expire on the earlier to occur of (i) 5:00 pm ET on February 6, 2012 and (ii) ten business days after notice from the Issuer that the closing price of the common stock has been greater than $3.00 per share for a period of 30 consecutive trading days. Anthony B. Evnin 2007-02-08